Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An independent observational study to compare the effectiveness of cytisine and nicotine replacement therapy (NRT) as an aid to smoking cessation

Trial Profile

An independent observational study to compare the effectiveness of cytisine and nicotine replacement therapy (NRT) as an aid to smoking cessation

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Sep 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cytisine (Primary) ; Nicotine replacement therapy
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2018 New trial record
    • 18 Sep 2018 According to an Achieve Life Sciences media release, data from this trial has been published in the International Journal of Drug Policy (August 2018).
    • 18 Sep 2018 Results presented in the Achieve Life Sciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top